Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-02-03 @ 4:16 PM
Study NCT ID:
NCT00895934
Status:
COMPLETED
Last Update Posted:
2019-05-23
First Post:
2009-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML
Sponsor:
Organization: